Yantacaw Capital
Venture fund · from SEC filings

New Leaf Biopharma Opportunities II, L.P.

New Leaf Venture Partners · adviser of record: New Leaf Venture Partners LLC · 2018 vintage

New Leaf Biopharma Opportunities II, L.P. is a 2018 venture fund managed by New Leaf Venture Partners, with $200mm raised (Form D, amount sold). It reported $121mm in gross assets at year-end 2025, 0.60x its size, against a peak of $156mm in 2021.

Latest value held
$121mm year-end 2025
Peak
$156mm year-end 2021
Fund size
$200mm Form D, amount sold
Held vs. size
0.60x peak 0.78x

Value held by year-end

$50mm$100mm$150mm$200mm20182019202020212022202320242025

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2025$121mm0.60x-7% over 2 yrs
2023$130mm0.65x+1%
2022$129mm0.64x-17%
2021$156mm0.78x+3%
2020$152mm0.76x+16%
2019$132mm0.66x+28%
2018$103mm0.51x–

What public pensions report

InvestorAs ofCommitmentCash back (DPI)Total (TVPI)Still held
Michigan SMIB2025-12-31–––$98.5mm

Latest report from each pension, as multiples of paid-in capital. Michigan reports dollar value held, shown under Still held.

Other funds from New Leaf Venture Partners

All New Leaf Venture Partners funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-5167036455. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.